[Development of catheter ablation of supraventricular tachycardias with special consideration of contributions from German engineers and electrophysiologists].

Gerhard Hindricks, Verena Tscholl, Nikolaos Dagres, Philipp Attanasio, Martin Huemer

Abstract readEnglish AbstractReview

In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gerhard HindricksDeutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland. Gerhard.Hindricks@dhzc-charite.de.

Verena TschollDeutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland.

Nikolaos DagresDeutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland.

Philipp AttanasioDeutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland.

Martin HuemerDeutsches Herzzentrum der Charité, Campus Charité Mitte, Berlin, DE, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development and clinical implementation of catheter ablation of supraventricular tachycardia is one of the outstanding achievements of modern cardiovascular treatment. Over a period of less than 40 years, a curative and safe treatment strategy for almost all forms of atrial arrhythmias has been developed and implemented. German electrophysiologists and engineers have made a significant contribution to this truly outstanding success story in modern medicine. Their contributions should be appropriately acknowledged because without them, the development of ablation technology and its worldwide dissemination would not have been possible. Both the technological contributions and the medical-electrophysiological contributions were at the absolute forefront of worldwide developments and have made a significant contribution to the fact that today more than 500,000 patients with symptomatic and/or threatening cardiac arrhythmias can be successfully treated every year by use of catheter ablation. We would like to thank them all for their achievements.

Indexed as

Catheter AblationTachycardia, SupraventricularArrhythmias, CardiacCardiac ElectrophysiologyHumansAtrial fibrillationCardiac arrhythmiasCatheter ablationSupraventricular arrhythmias

Identifiers

PMID38416159

DOI10.1002/hsr2.1741

PMCPMC10923970

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.